论文部分内容阅读
我国育龄妇女不孕症的发生率约为10%,排卵障碍引起的不孕占不孕症15%~25%。近20年来妇科内分泌学的最大进展之一就是应用人促性腺激素(HMG)治疗排卵功能障碍,并获得满意疗效。本组自1987年7月到1988年9月,采用国产HMG治疗排卵障碍8例,治疗过程用BBT,阴道细胞学涂片,宫颈粘液评分,B型超声波等进行监测[1],8例共16个周期,获得较好疗效。现报道如下:
The incidence of infertility in Chinese women of childbearing age is about 10%, infertility caused by ovulation disorders accounts for 15% ~ 25% of infertility. In the past 20 years, one of the greatest progresses of gynecological endocrinology is the application of human gonadotropin (HMG) in the treatment of ovulatory dysfunction and to obtain satisfactory curative effect. This group from July 1987 to September 1988, the use of domestic HMG treatment of ovulation disorders in 8 cases, the course of treatment with BBT, vaginal cytology smears, cervical mucus score, B-mode ultrasound monitoring [1], 8 cases of total 16 cycles, get better curative effect. Reported as follows now: